Drug Delivery Implants in the Treatment of Vitreous Inflammation
The eye is a model organ for the local delivery of therapeutics. This proves beneficial when treating vitreous inflammation and other ophthalmic pathologies. The chronicity of certain diseases, however, limits the effectiveness of locally administered drugs. To maintain such treatments often require...
Saved in:
| Main Authors: | Jillian Wang, Angela Jiang, Malav Joshi, John Christoforidis |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2013-01-01
|
| Series: | Mediators of Inflammation |
| Online Access: | http://dx.doi.org/10.1155/2013/780634 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Vitreous Inflammation Associated with Intravitreal Anti-VEGF Pharmacotherapy
by: Shivi Agrawal, et al.
Published: (2013-01-01) -
Thermal ocular injury associated with retinal necrosis and vitreous inflammation: a case report
by: Ruiping Gu, et al.
Published: (2025-06-01) -
Vitreous Substitutes
by: Shorya Vardhan Azad, et al.
Published: (2012-07-01) -
Intravitreal Inflammation: From Benchside to Bedside 2013
by: Mario R. Romano, et al.
Published: (2014-01-01) -
The multifaceted role of vitreous hyalocytes: Orchestrating inflammation, angiomodulation and erythrophagocytosis in proliferative diabetic retinopathy
by: Stefaniya K. Boneva, et al.
Published: (2024-11-01)